Pioneering molecular screening for cervical precursor lesions and cervical cancer in sera.

Autor: Miranda-Falconi P; Women's Medical Center, Ginequito Hospital, Monterrey, Nuevo Leon, Mexico., Flores-Peña G; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Jiménez-Trejo MF; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Torres-Paz YE; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Reyes-Hernández DO; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Estrada-Guzmán JC; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Hernández-Ramírez E; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Torres-Torralba EN; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Rangel-Ordoñez JP; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Vejar-Galicia DK; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Reyes-Fonseca P; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Islas-Bayona OP; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Hernández-Paredes R; Molecular Laboratory, TIMSER Group, Mexico City, Mexico., Gutiérrez M; Research Department, ATSO Pharma, Mexico City, Mexico., Santillán O; Research Department, ATSO Pharma, Mexico City, Mexico.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Nov 14; Vol. 14, pp. 1483882. Date of Electronic Publication: 2024 Nov 14 (Print Publication: 2024).